[1]FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors. Retrieved January 9, 2020, from https://www.fda.gov/news-events/press-announcements/fda-appro.....
[1] ADC Therapeutics Announces Positive Results from Pivotal Phase 2 Clinical Trial of Single Agent Loncastuximab Tesirine (ADCT-402) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,Retrie.....
[1] US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma,Retrieved January 21, 2020, from https://www.prnewswire.com/new.....
编译:菜菜_AM@微博/作者:世界卫生组织(WHO)来源:肿瘤资讯1月20日,世界卫生组织(WHO)出了一份"Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild sympto